PCR is an enzymatic reaction process in which multiple copies of desired DNA sequence is obtained in a short period of time. The technique is broadly accepted in research and clinical diagnostic application due to its high accuracy and sensitivity. The evolution of PCR instruments with different designs such as interchangeable modules, dual & multiblock capacity, development of advanced Real-time PCR and digital PCR with multiplexing and analytical capabilities, development of various reagents & consumables and incorporation of microfluidic and other advanced technologies for the development of portable PCR will further advance the PCR applications in clinical diagnostic and industrial applications.
The Polymerase Chain Reaction (PCR) global market is estimated to be $21,408.8 million in 2020. The factors driving the market are raising the incidence of infectious and non-infectious diseases, increase in demand for early disease detection, diagnosis & treatment, growing focus towards the development of personalized medicine, increasing advancements in PCR technologies and increasing demand for point of care testing. However, lack of skilled personnel to use advanced PCR Instruments and data analysis software, high cost of advanced instruments, presence of alternative molecular and immunology techniques, and stringent government regulations are expected to hamper the market growth.
The PCR market is classified into products, application, end-user and geography. The PCR products global market is segmented into instruments, reagents & consumables and software & services. Among the products, the Reagents & consumables segment accounted for the largest revenue in 2020 due to an increase in demand for reagents & consumables for research and diagnostic applications. Reagents and consumables are sub-segmented into enzymes, dNTPs, template DNA, primers and probes, buffers, reagents kits or master mixes and assay kits, nuclease free water, consumable and others (dye and beads). Among these Reagents kits or master mixes and assay kits is accounted for the highest revenue in 2020 due to an increase in demand for assay kits in diagnostic applications particularly in COVID-19 diagnosis. The enzymes are fastest growing consumable segment at a high single digit CAGR from 2020 to 2027. The PCR instruments global market is sub-segmented into Standard PCR, Real-Time PCR and Digital PCR. Among the instruments, Real-Time PCR is accounted for the highest revenue in 2020 due to increased utilization of real-time PCR instruments in diagnostic applications particularly in COVID-19 diagnosis and research applications. The digital PCR is fastest growing instruments segment at a mid teen CAGR from 2020 to 2027.
The application market is segmented into clinical diagnostics, industrial applications, and others (blood screening and HLA typing). Among the applications, Clinical diagnostics is accounted for the highest revenue in 2020 due to an increase in demand for PCR-based diagnostic solutions. Industrial applications is fastest growing segment at a mid single digit CAGR from 2020 to 2027. The Clinical diagnostic market is sub-segmented into infectious diseases and non-infectious diseases. Among these, infectious diseases are accounted for the highest revenue in 2020 due to an increase in the incidence of infectious diseases, particularly in COVID-19. Non-infectious diseases is fastest growing segment at a double digit CAGR from 2020 to 2027. Infectious diseases are further segmented into Hepatitis B and C testing, Tuberculosis diagnosis, HIV diagnosis, COVID-19 diagnosis and other infectious diseases. Among these, COVID-19 diagnosis is accounted for the highest revenue in 2020 due to an increase in the incidence of COVID-19 and an increase in demand for PCR-based early diagnosis solutions. Hepatitis B and C testing is fastest growing segment at a low single digit CAGR from 2020 to 2027. Non-infectious diseases market is sub-segmented into Cancer, Genetic Testing and Others. Among these, the Cancer segment accounted for the highest revenue in 2020 and is expected to grow at a double digit CAGR from 2020 to 2027 due to the increase incidence and prevalence of cancer and increasing demand for early disease diagnosis solutions. The genetic testing is fastest growing segment at a low teen CAGR from 2020 to 2027. The industrial application market is further classified into Agriculture, Environment, Applied Testing, Animal Husbandry, Biomedical Research and Others. Among these, Biomedical Research is accounted for the highest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. The applied testing is fastest growing segment at a mid single digit CAGR from 2020 to 2027. The Biomedical Research market is further sub-segmented into DNA sequencing, Genotyping, Gene Expression Analysis, DNA cloning and others. Among these, DNA sequencing is accounted for the highest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. Genotyping is fastest growing segment at a mid single digit CAGR from 2020 to 2027. Applied testing is further segmented into forensics and food safety testing. Among them, Forensics is accounted for the highest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. Food safety testing is fastest growing segment high single digit CAGR from 2020 to 2027.
The end- user market is segmented into Hospitals and laboratories, Pharmaceuticals, CRO's and Biotech companies, Academics and Research institutions and others. Among these, Hospitals and laboratories accounted for the largest revenue in 2020 due to an increase in demand for PCR-based early diagnosis tastings. Academics and Research institutions is fastest growing segment at a mid single digit CAGR from 2020 to 2027.
By geography, the PCR global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K. and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and the Rest of the world (Brazil, Rest of Latin America and the Middle East & Africa). North America accounted for the largest revenue in 2020. The factors such as increasing R&D and health care expenditure, increase in the incidence of infectious diseases particularly COVID-19 and non-infectious diseases with increased demand for early detection, diagnosis & treatment, increasing funding from the government for the disease research, development of diagnostic and therapeutic solutions, growing focus towards personalized medicine and a growing number of startup companies engaged in developing advanced digital PCR systems & portable PCR solutions to use in research & diagnostics are driving the market.
The PCR global market is competitive and all the players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the PCR global market include Abbott Laboratories, Inc. (U.S.), F.Hoffmann-La Roche Ltd (Switzerland), Biomerieux SA (France), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), Qiagen N.V. (Netherlands) and Thermo Fisher Scientific, Inc. (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
North America
- U.S.
- Rest of North America
Europe
- Germany
- U.K.
- France
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of APAC
Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East and Africa
Table of Contents
1 Executive Summary
2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown and Data Triangulation
2.6.3 Secondary Sources
2.6.4 Key Data Points from Secondary Sources
2.6.5 Primary Sources
2.6.6 Key Data Points from Primary Sources
2.6.7 Assumptions
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Rising Incidence of Infectious and Non-Infectious Diseases and Demand for Early Detection, Diagnosis & Treatment
3.3.1.2 Increasing Focus Towards the Development of Personalized Medicines
3.3.1.3 Growing Demand for Point of Care Testing
3.3.1.4 Increasing Demand for Prenatal Testing
3.3.2 Restraints and Threats
3.3.2.1 Lack of Skilled Personnel to Use Advanced Instruments
3.3.2.2 High Cost of Advanced PCR System
3.3.2.3 Development of Alternate Technologies
3.3.2.4 Stringent Regulatory Framework Limits Advancements in the PCR Market
3.4 Regulatory Affairs
3.4.1 U.S.
3.4.2 Europe
3.4.3 China
3.4.4 India
3.4.5 Japan
3.5 Porter's Five Force Analysis
3.5.1 Threat of New Entrants
3.5.2 Threat of Substitutes
3.5.3 Bargaining Power of Suppliers
3.5.4 Bargaining Power of Buyers
3.5.5 Competitive Rivalry
3.6 Supply Chain Analysis
3.7 Funding Scenario
3.8 Patent Analysis
3.9 Technological Advancements
3.9.1 Introduction
3.9.2 Crystal Digital PCR Technology
3.9.3 Real Time Remote Monitoring
3.9.4 Artificial Intelligence in PCR
3.9.5 Infrared Mediated Non-Contact Thermocycling
3.9.6 Nano-PCR
3.10 Impact of Covid-19 on PCR Market
3.11 Market Share Analysis by Major Players
3.11.1 PCR Global Market Share Analysis
3.11.2 Standard PCR Global Market Share Analysis
3.11.3 Real Time PCR Global Market Share Analysis
3.11.4 Digital PCR Global Market Share Analysis
4 PCR Global Market, by Product
4.1 Introduction
4.2 Instruments
4.2.1 Standard PCR
4.2.2 Real Time PCR
4.2.3 Digital PCR
4.3 Reagents and Consumables
4.3.1 Enzymes
4.3.2 Deoxynucleotide Triphosphate's (Dntp's)
4.3.3 Templates or Controls
4.3.4 Primers and Probes
4.3.5 Buffers
4.3.6 Reagent Kits or Master Mixes and Assay Kits
4.3.7 Nuclease Free Water
4.3.8 Consumables
4.3.9 Other Reagents and Consumables
4.4 Software & Services
5 PCR Global Market, by Application
5.1 Introduction
5.2 Clinical Diagnostics
5.2.1 Infectious Diseases
5.2.1.1 Hepatitis B and C Testing
5.2.1.2 Tuberculosis Diagnosis
5.2.1.3 Hiv Diagnosis
5.2.1.4 Covid-19 Diagnosis
5.2.1.5 Others
5.2.2 Non-Infectious Diseases
5.2.2.1 Cancer
5.2.2.2 Genetic Testing
5.2.2.3 Others
5.3 Industrial Applications
5.3.1 Agriculture
5.3.2 Environment
5.3.3 Applied Testing
5.3.3.1 Forensics
5.3.3.2 Food Safety Testing
5.3.4 Animal Husbandry
5.3.5 Biomedical Research
5.3.5.1 Dna Sequencing
5.3.5.2 Genotyping
5.3.5.3 Gene Expression Analysis
5.3.5.4 Dna Cloning
5.3.5.5 Others
5.3.6 Other PCR Industry Applications
5.4 Other PCR Applications
6 PCR Global Market, by End-Users
6.1 Introduction
6.2 Hospitals and Laboratories
6.3 Pharmaceuticals, Cro's and Biotech
6.4 Academics and Research Institutions
6.5 Others
7 Regional Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Rest of North America
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia-Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Rest of Apac
7.5 RoW
7.5.1 Brazil
7.5.2 Rest of Latin America
7.5.3 Middle East & Africa
8 Competitive Landscape
8.1 Introduction
8.2 Approvals
8.3 New Product Launch
8.4 Collaborations and Partnerships
8.5 Acquisitions
8.6 Others
9 Major Companies
9.1 Abbott Laboratories, Inc.
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Key Developments
9.1.5 Business Strategy
9.1.6 SWOT Analysis
9.2 Becton Dickinson and Company
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Key Developments
9.2.5 Business Strategy
9.2.6 SWOT Analysis
9.3 Biomerieux Sa
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Key Developmensts
9.3.5 Business Strategy
9.3.6 SWOT Analysis
9.4 Bio-Rad Laboratories
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Key Developments
9.4.5 Business Strategy
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Key Developments
9.5.5 Business Strategy
9.5.6 SWOT Analysis
9.6 Exact Sciences Corporation
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Key Developments
9.6.5 Business Strategy
9.6.6 SWOT Analysis
9.7 F.Hoffmann-La Roche Ltd
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Key Developments
9.7.5 Business Strategy
9.7.6 SWOT Analysis
9.8 Merck Kgaa
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Key Developments
9.8.5 Business Strategy
9.8.6 SWOT Analysis
9.9 Perkinelmer, Inc.
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Key Developments
9.9.5 Business Strategy
9.9.6 SWOT Analysis
9.10 Qiagen N.V.
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Key Developments
9.10.5 Business Strategy
9.10.6 SWOT Analysis
9.11 Thermo Fisher Scientific, Inc.
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Key Developments
9.11.5 Business Strategy
9.11.6 SWOT Analysis
List of Tables
Table 1 PCR Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 2 PCR Global Market Revenue, by Product, (2019-2027) ($Mn)
Table 3 Instruments Global Market Revenue, by Type, (2019-2027) ($Mn)
Table 4 Instruments Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 5 Standard PCR Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 6 Real Time PCR Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 7 Digital PCR Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 8 Reagents & Consumables Global Market Revenue, by Type, (2019-2027) ($Mn)
Table 9 Reagents and Consumables Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 10 Enzymes Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 11 Dntp's Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 12 Templates or Controls Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 13 Primers and Probes Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 14 Buffers Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 15 Reagent Kits or Master Mixes and Assay Kits Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 16 Nuclease Free Water Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 17 Consumables Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 18 Other Reagents and Consumables Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 19 Software & Services Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 20 PCR Global Market Revenue, by Application, (2019-2027) ($Mn)
Table 21 Clinical Diagnostics Global Market Revenue, by Application Type, (2020-2027) ($Mn)
Table 22 Clinical Diagnostics Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 23 Infectious Diseases Global Market Revenue, by Disease Type, (2019-2027) ($Mn)
Table 24 Infectious Diseases Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 25 Hepatitis B and C Testing Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 26 Tuberculosis Diagnosis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 27 Hiv Diagnosis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 28 Covid-19 Diagnosis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 29 Others Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 30 Non-Infectious Diseases Global Market Revenue, by Type, (2019-2027) ($Mn)
Table 31 Non-Infectious Diseases Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 32 Cancer Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 33 Genetic Testing Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 34 Others Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 35 Industrial Applications Global Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 36 Industrial Applications Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 37 Agriculture Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 38 Environment Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 39 Applied Testing Global Market Revenue, by Type, (2019-2027) ($Mn)
Table 40 Applied Testing Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 41 Forensics Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 42 Food Safety Testing Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 43 Animal Husbandry Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 44 Biomedical Research Global Market Revenue, by Type, (2019-2027) ($Mn)
Table 45 Biomedical Research Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 46 Dna Sequencing Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 47 Genotyping Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 48 Gene Expression Analysis Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 49 Dna Cloning Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 50 Others Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 51 Other PCR Industry Applications Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 52 Other PCR Applications Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 53 PCR Global Market Revenue, by End-Users, (2019-2027) ($Mn)
Table 54 Hospitals and Laboratories Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 55 Pharmaceuticals, Cro's and Biotech Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 56 Academics and Research Institutions Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 57 Others Market Revenue, by Region, (2019-2027) ($Mn)
Table 58 PCR Global Market Revenue, by Region, (2019-2027) ($Mn)
Table 59 North America PCR Market Revenue, by Product, (2019-2027) ($Mn)
Table 60 North America Instruments Market Revenue, by Type, (2019-2027) ($Mn)
Table 61 North America Reagents & Consumables Market Revenue, by Type, (2019-2027) ($Mn)
Table 62 North America PCR Market Revenue, by Application, (2019-2027) ($Mn)
Table 63 North America Clinical Diagnostics Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 64 North America Infectious Diseases Market Revenue, by Disease Type, (2019-2027) ($Mn)
Table 65 North America Non-Infectious Diseases Market Revenue, by Type, (2019-2027) ($Mn)
Table 66 North America Industrial Applications Market Revenue, by Type, (2019-2027) ($Mn)
Table 67 North America Applied Testing Market Revenue, by Type, (2019-2027) ($Mn)
Table 68 North America Biomedical Research Market Revenue, by Type, (2019-2027) ($Mn)
Table 69 North America PCR Market Revenue, by End-Users, (2019-2027) ($Mn)
Table 70 North America PCR Market Revenue, by Country, (2019-2027) ($Mn)
Table 71 Europe PCR Market Revenue, by Product, (2019-2027) ($Mn)
Table 72 Europe Instruments Market Revenue, by Type, (2019-2027) ($Mn)
Table 73 Europe Reagents & Consumables Market Revenue, by Type, (2019-2027) ($Mn)
Table 74 Europe PCR Market Revenue, by Application, (2019-2027) ($Mn)
Table 75 Europe Clinical Diagnostics Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 76 Europe Infectious Diseases Market Revenue, by Disease Type, (2019-2027) ($Mn)
Table 77 Europe Non-Infectious Diseases Market Revenue, by Type, (2019-2027) ($Mn)
Table 78 Europe Industrial Applications Market Revenue, by Type, (2019-2027) ($Mn)
Table 79 Europe Applied Testing Market Revenue, by Type, (2019-2027) ($Mn)
Table 80 Europe Biomedical Research Market Revenue, by Type, (2019-2027) ($Mn)
Table 81 Europe PCR Market Revenue, by End-Users, (2019-2027) ($Mn)
Table 82 Europe PCR Market Revenue, by Country, (2019-2027) ($Mn)
Table 83 Asia-Pacific PCR Market Revenue, by Product, (2019-2027) ($Mn)
Table 84 Asia-Pacific Instruments Market Revenue, by Type, (2019-2027) ($Mn)
Table 85 Asia-Pacific Reagents & Consumables Market Revenue, by Type, (2019-2027) ($Mn)
Table 86 Asia-Pacific PCR Market Revenue, by Application, (2019-2027) ($Mn)
Table 87 Asia-Pacific Clinical Diagnostics Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 88 Asia-Pacific Infectious Diseases Market Revenue, by Disease Type, (2019-2027) ($Mn)
Table 89 Asia-Pacific Non-Infectious Diseases Market Revenue, by Type, (2019-2027) ($Mn)
Table 90 Asia-Pacific Industrial Applications Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 91 Asia-Pacific Applied Testing Market Revenue, by Type, (2019-2027) ($Mn)
Table 92 Asia-Pacific Biomedical Research Market Revenue, by Type, (2019-2027) ($Mn)
Table 93 Asia-Pacific PCR Market Revenue, by End-Users, (2019-2027) ($Mn)
Table 94 Asia-Pacific PCR Market Revenue, by Country, (2019-2027) ($Mn)
Table 95 RoW PCR Market Revenue, by Product, (2019-2027) ($Mn)
Table 96 RoW Instruments Market Revenue, by Type, (2019-2027) ($Mn)
Table 97 RoW Reagents & Consumables Market Revenue, by Type, (2019-2027) ($Mn)
Table 98 RoW PCR Market Revenue, by Application, (2019-2027) ($Mn)
Table 99 RoW Clinical Diagnostics Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 100 RoW Infectious Diseases Market Revenue, by Disease Type, (2019-2027) ($Mn)
Table 101 RoW Non-Infectious Diseases Market Revenue, by Type, (2019-2027) ($Mn)
Table 102 RoW Industrial Applications Market Revenue, by Application Type, (2019-2027) ($Mn)
Table 103 RoW Applied Testing Market Revenue, by Type, (2019-2027) ($Mn)
Table 104 RoW Biomedical Research Market Revenue, by Type, (2019-2027) ($Mn)
Table 105 RoW PCR Market Revenue, by End-Users, (2019-2027) ($Mn)
Table 106 RoW PCR Market Revenue, by Country, (2019-2027) ($Mn)
Table 107 Approvals (2020-2021*)
Table 108 New Product Launch (2020-2021*)
Table 109 Collaborations and Partnerships (2020-2021*)
Table 110 Acquisitions (2020-2021*)
Table 111 Others (2020-2021*)
Table 112 Abbott Laboratories, Inc.: Total Revenue and R&D Expenses, (2019-2021) (Q1) ($Mn)
Table 113 Abbott Laboratories, Inc.: Total Revenue, by Segments, (2019-2021) (Q1) ($Mn)
Table 114 Abbott Laboratories, Inc.: Diagnostics Revenue, by Sub-Segments, (2019-2021) (Q1) ($Mn)
Table 115 Abbott Laboratories, Inc.: Total Revenue, by Geography, (2019-2021) (Q1) ($Mn)
Table 116 Becton Dickinson and Company: Total Revenue and R&D Expenses, (2019-2021) (Q2) ($Mn)
Table 117 Becton Dickinson and Company: Total Revenue, by Segments, (2019-2021) (Q2) ($Mn)
Table 118 Becton Dickinson and Company: Life Sciences Revenue, by Sub-Segments, (2019-2021) (Q2) ($Mn)
Table 119 Becton Dickinson and Company: Total Revenue, by Geography, (2019-2021) (Q2) ($Mn)
Table 120 Biomerieux: Total Revenue and R&D Expenses, (2019-2021) (Q1) ($Mn)
Table 121 Biomeuriex: Total Revenue, by Segments, (2019-2021) (Q1) ($Mn)
Table 122 Biomeuriex: Total Revenue, by Geography, (2019-2021) (Q1) ($Mn)
Table 123 Bio-Rad Laboratories: Total Revenue and R&D Expenses, (2019-2021) (Q1) ($Mn)
Table 124 Bio-Rad Laboratories: Total Revenue, by Segments, (2019-2021) (Q1) ($Mn)
Table 125 Bio-Rad Laboratories: Total Revenue, by Geography, (2019-2021) (Q1) ($Mn)
Table 126 Danaher Corporation: Total Revenue and R&D Expenses (2019-2021) (Q1) ($Mn)
Table 127 Danaher Corporation: Total Revenue, by Segment, (2019-2021)(Q1) ($Mn)
Table 128 Danaher Corporation: Total Revenue, by Region, (2019-2021) (Q1) ($Mn)
Table 129 Exact Sciences Corporation: Total Revenue and R&D Expenses, (2019-2021) (Q1) ($Mn)
Table 130 Exact Sciences Corporation: Total Revenue, by Segment, (2019-2021) (Q1) ($Mn)
Table 131 Exact Sciences Corporation: Total Revenue, by Geography, (2019-2021) (Q1)($Mn)
Table 132 F.Hoffmann-La Rache: Total Revenue and R&D Expenses, (2019-2021) (Q1) ($Mn)
Table 133 F.Hoffmann-La Roche: Total Revenue, by Segments, (2019-2021) (Q1) ($Mn)
Table 134 F.Hoffmann-La Roche: Diagnostics Revenue, by Segments (2019-2021) (Q1) ($Mn)
Table 135 F.Hoffman La Roche: Diagnostics Revenue, by Geography, (2019-2021) (Q1) ($Mn)
Table 136 Merck Kgaa: Total Revenue and R&D Expenses, (2019-2020) (Q1) ($Mn)
Table 137 Merck Kgaa: Total Revenue, by Segments, (2019-2021) (Q1) ($Mn)
Table 138 Merck Kgaa Company: Total Revenue, by Life-Science Sub-Segments, (2019-2021) (Q1) ($Mn)
Table 139 Merck Kgaa: Total Revenue, by Geography, (2019-2021) (Q1) ($Mn)
Table 140 Perkinelmer, Inc.: Total Revenue and R&D Expenses, (2019-2021) (Q1) ($Mn)
Table 141 Perkinelmer, Inc.: Total Revenue by Segment, (2019-2021) (Q1) ($Mn)
Table 142 Perkinelmer, Inc.: Total Revenue, by Region, (2019-2021) (Q1) ($Mn)
Table 143 Qiagen N.V.: Total Revenue and R&D Expenses, (2019-2021)(Q1) ($Mn)
Table 144 Qiagen N.V.: Total Revenue, by Segments, (2019-2021) (Q1) ($Mn)
Table 145 Qiagen N.V.: Total Revenue, by Geography, (2019-2021) (Q1) ($Mn)
Table 146 Thermofisher Scientific, Inc.: Total Revenue and R&D Expenses, (2019-2021) (Q1) ($Mn)
Table 147 Thermo Fisher Scientific, Inc.: Total Revenue, by Segments, (2019-2021) (Q1) ($Mn)
Table 148 Thermo Fisher Scientific, Inc.: Total Revenue, by Geography, (2019-2021) (Q1) ($Mn)
List of Figures
Figure 1 PCR Global Market Revenue, by Region (2019-2027) ($Mn)
Figure 2 Research Methodology: PCR Global Market
Figure 3 PCR Global Market: Top-Down and Bottom-Up Approach
Figure 4 PCR Global Market: Forecasting Model
Figure 5 PCR Global Market: Market Breakdown and Data Triangulation
Figure 6 PCR Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 PCR Global Market: Porter's Analysis
Figure 9 PCR Global Market: Supply Chain Analysis
Figure 10 PCR Market: Patent Filing by Major Players(2017-2021*)
Figure 11 PCR Global Market Share Analysis, by Key Players, 2020 (%)
Figure 12 Standard PCR Global Market Share Analysis, by Key Players, 2020 (%)
Figure 13 Real Time PCR Global Market Share Analysis, by Key Players, 2020 (%)
Figure 14 Digital Global Market Share Analysis, by Key Players, 2020 (%)
Figure 15 PCR Global Market Share, by Product (2020 V/S 2027) (%)
Figure 16 Instruments Global Market Share, by Type (2020 V/S 2027) (%)
Figure 17 Types of Instruments Based on Sample Holding Capacity, Portability and Mechanism of Operation
Figure 18 Reagents and Consumables Global Market Share, by Type (2020 V/S 2027) (%)
Figure 19 Reagents and Consumables Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 20 Enzymes Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 21 Dntp's Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 22 Templates or Controls Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 23 Primers and Probes Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 24 Buffers Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 25 Reagent Kits or Master Mixes and Assay Kits Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 26 Consumables Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 27 Other Reagents and Consumables Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 28 PCR Global Market Share, by Application (2020 V/S 2027) (%)
Figure 29 Clinical Diagnostics Global Market Share, by Applicattion Type (2020 V/S 2027) (%)
Figure 30 Clinical Diagnostics Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 31 Infectious Diseases Global Market Share, by Type (2020 V/S 2027) (%)
Figure 32 Infectious Diseases Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 33 Hiv Diagnosis Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 34 Covid-19 Diagnosis Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 35 Non-Infectious Diseases Global Market Share, by Type (2020 V/S 2027) (%)
Figure 36 Non-Infectious Diseases Global Market Share, by Region, (2020 V/S 2027 (%)
Figure 37 Genetic Testing Global Market Share, by Region, (2020 V/S 2027 (%)
Figure 38 Others Global Market Share, by Region, (2020 V/S 2027 (%)
Figure 39 Industrial Applications Global Market Share, by Application Type, Biomedical Reseaech and Applied Testing Global Market Share, by Type (2020) (%)
Figure 40 Industrial Applications Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 41 Environment Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 42 Applied Testing Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 43 Forensics Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 44 Biomedical Research Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 45 Dna Sequencing Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 46 Genotyping Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 47 PCR Global Market Share, by End-Users (2020 V/S 2027) (%)
Figure 48 Pharmaceuticals, Cro's and Biotech Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 49 Academics and Research Institutions Global Market Share, by Region, (2020 V/S 2027) (%)
Figure 50 PCR Global Market Revenue, by Region (2019-2027) ($Mn),
Figure 51 PCR Global Market Revenue, by Geography (2020) ($ Mn)
Figure 52 North America PCR Market Share, by Product (2020 V/S 2027) (%)
Figure 53 North America Instrument Market Share, by Type (2020 V/S 2027) (%)
Figure 54 North America Reagents and Consumables Market Share, by Type (2020 V/S 2027) (%)
Figure 55 North America PCR Market Share, by Application (2020 V/S 2027) (%)
Figure 56 North America Clinical Diagnostics Market Share, by Type (2020 V/S 2027) (%)
Figure 57 North America Infectious Diseases Market Share, by Type (2020 V/S 2027) (%)
Figure 58 North America Non-Infectious Diseases Market Share, by Type (2020 V/S 2027) (%)
Figure 59 North America Industrial Applications Marker Share by Application Type, Biomedical Reserch, Applied Testing Market Share, by Type (2020) (%)
Figure 60 North America PCR Market Share, by End-User (2020 V/S 2027) (%)
Figure 61 North America PCR Market Share, by Country (2020 V/S 2027) (%)
Figure 62 U.S. PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 63 Rest of North America PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 64 Europe PCR Market Share, by Product (2020 V/S 2027) (%)
Figure 65 Europe Instrument Market Share, by Type (2020 V/S 2027) (%)
Figure 66 Europe Reagents and Consumables Market Share, by Type (2020 V/S 2027) (%)
Figure 67 Europe PCR Market Share, by Applications (2020 V/S 2027) (%)
Figure 68 Europe Clinical Diagnostics Market Share, by Application Type (2020 V/S 2027) (%)
Figure 69 Europe Infectious Diseases PCR Market Share, by Disease Type (2020 V/S 2027) (%)
Figure 70 Europe Non-Infectious Diseases Market Share, by Type (2020 V/S 2027) (%)
Figure 71 Europe Industrial Applications Market Share, by Application Type, Biomedical Research and Applied Testing Market Share, by Type (2020) (%)
Figure 72 Europe PCR Market Share, by End-Users (2020 V/S 2027) (%)
Figure 73 Europe PCR Market Share, by Country (2020 V/S 2027) (%)
Figure 74 Germany PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 75 U.K. PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 76 France PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 77 Rest of Europe PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 78 Asia-Pacific PCR Market Share, by Products (2020 V/S 2027) (%)
Figure 79 Asia-Pacific Instruments Market Share, by Type (2020 V/S 2027) (%)
Figure 80 Asia-Pacific Reagents and Consumables Market Share, by Type (2020 V/S 2027) (%)
Figure 81 Asia-Pacific PCR Market Share, by Applications (2020 V/S 2027) (%)
Figure 82 Asia-Pacific Clinical Diagnostic Market Share, by Application Type (2020 V/S 2027) (%)
Figure 83 Asia-Pacific Infectious Diseases Market Share, by Disease Type (2020 V/S 2027) (%)
Figure 84 Asia-Pacific Non-Infectious Diseases Market Share, by Type (2020 V/S 2027) (%)
Figure 85 Asia-Pacific Industrial Applications Market Share, By, Application Type, Biomedical Research and Applied Testing Market Share, by Type (2020) (%)
Figure 86 Asia-Pacific PCR Market Share, by End-User (2020 V/S 2027) (%)
Figure 87 Asia-Pacific PCR Market Share, by Country (2020 V/S 2027) (%)
Figure 88 Japan PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 89 China PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 90 India PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 91 Rest of APAC PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 92 RoW PCR Market Share, by Products (2020 V/S 2027) (%)
Figure 93 RoW Instruments Market Share, by Type (2020 V/S 2027) (%)
Figure 94 RoW Reagents and Consumables Market Share, by Type (2020 V/S 2027) (%)
Figure 95 RoW PCR Market Share, Applications (2020 V/S 2027) (%)
Figure 96 RoW Clinical Diagnostics Market Share, by Applicaion Type (2020 V/S 2027) (%)
Figure 97 RoW Infectious Diseases Market Share, by Disease Type (2020 V/S 2027) (%)
Figure 98 RoW Non-Infectious Diseases Market Share, by Type (2020 V/S 2027) (%)
Figure 99 RoW Industrial Applications Market Share, by Application Type, Biomedical Research and Applied Testing Market Share Type (2020) (%)
Figure 100 RoW PCR Market Share, by End-User (2020 V/S 2027) (%)
Figure 101 RoW PCR Market Share, by Country (2020 V/S 2027) (%)
Figure 102 Brazil PCR Market Revenue, by Products, Application and End-Users (2020 Vs 2027) ($Mn)
Figure 103 Rest of Latin America PCR Market Revenue, by Products, Application and End-Users (2020 Vs 2027) ($Mn)
Figure 104 Middle East & Africa PCR Market Revenue, by Product, Application and End-User (2020 V/S 2027) ($Mn)
Figure 105 Key Growth Strategies, (2020-2021*)
Figure 106 SWOT: Abbott Laboratories, Inc.
Figure 107 SWOT: Becton Dickinson and Company
Figure 108 SWOT: Biomerieux
Figure 109 SWOT: Bio-Rad Laboratories
Figure 110 SWOT: Danaher Corporation
Figure 111 SWOT: Exact Sciences Corporation
Figure 112 SWOT: F. Hoffmann-La Roche Ltd.
Figure 113 SWOT: Merck Kgaa
Figure 114 SWOT: Perkinelmer, Inc
Figure 115 SWOT: Qiagen N.V.
Figure 116 SWOT: Thermo Fisher Scientific
Companies Mentioned
- B BlackBio Biotech India Limited
- 3CR Bioscience
- Abbott Laboratories, Inc.
- ACTGene, Inc.
- ADS Biotec, Inc.
- Agilent Technologies
- Ahram Biosystems, Inc.
- Altona Diagnostics GmbH
- Amoy Diagnostics
- Ampliqon A/S
- Analytik Jena AG
- Anatolia Geneworks
- Andiatec GmbH
- AniCon Labor GmbH
- Anitoa Systems, LLC
- Atila Bio Systems Inc
- Becton Dickinson and Company
- BforCure
- BGI Group
- Binx Health Inc.
- Bio Basic Inc.
- BioCheck, Inc.
- Biofidelity
- BioinGentech ,
- BIOLABMIX LLC
- Biomeme, Inc
- Biomerieux SA
- Bioneer Corporation
- Bio-Rad Laboratories, Inc.
- Bioron GmbH
- Biosynex S.A.
- Biotecon Diagnostics GmbH
- Biotype Diagnostic GmbH
- Blue-Ray Biotech
- Brooks Life Sciences
- Bruker
- CareDx, Inc.
- Carpegen GmbH
- Chai Inc.
- Cleaver Scientific Ltd.
- CLONIT Srl.
- Co-Diagnostics
- Combinati INC
- Convergent-technologies
- Corning, Inc.
- CyberGene AB
- Da An Gene Co.
- Danaher Corporation
- Devyser AB
- DiaCarta, Inc.
- DiaSorin S.p.A.
- Dropworks, Inc.
- Entopsis, Inc.
- EntroGen
- Eppendorf, AG
- Eurofins Scientific S.E.
- Exact sciences
- F.Hoffmann-La Roche AG
- Fluidigm corporation
- Genedrive plc
- GeneFirst Ltd.
- Genekam Biotechnology AG
- GeneProof A.S.
- Genesystem.co.kr
- Genome Diagnostics B.V.
- Genome Diagnostics Pvt Ltd.
- Genomed
- Genomictree Inc.
- GNA Biosolutions GmbH
- Hangzhou LongGene Scientific Instruments Co.,Ltd
- Hologics
- Hy Laboratories Ltd.
- Hygiena, LLC
- INTAS Science Imaging Instruments GmbH
- Invivoscribe, Inc
- Jena Bioscience GmbH
- JN Medsys
- Kaneka Eurogentec S.A.
- Kogene.co.kr
- KOMA Biotech, Inc.
- Kyratec
- LABGENE Scientific SA
- Macrogen Inc.
- Menarini Diagnostics
- Merck KgaA
- Meridian Bioscience
- MicroGEM
- Minerva Biolabs GmbH
- miniPCR bio
- Minute Molecular Diagnostics
- Molbio Diagnostics Pvt. Ltd.
- Molzym GmbH & Co. KG
- Mylab Discovery Solutions
- Nimagen B.V.
- Norgen Biotech Corp.
- Novacyt
- Nuclein, LLC.
- Ocimum Biosolutions, Ltd
- Pathofinder B.V.
- PCR Biosystems Ltd
- PCR Max Ltd.
- PentaBase ApS
- Perkin Elmer
- Precipio, Inc.
- Premier Biosoft International
- Promega Corporation
- Qiagen N.V.
- Qualiplante SAS
- QuantuMDx
- Quidel Corporation
- Reagecon Diagnostics Ltd.
- Scope Fluidics
- Seegene, Inc.
- Siemens Healthcare GmbH
- Sinaclon
- SolGent co, LTD
- SpeeDx
- Star Array company
- Stilla Technologies
- Takara Bio Inc.
- Tetracore, Inc.
- Thermo Fisher Scientific, Inc.
- Ubiquitome
- Vircell S.L.
- Visby Medical
- Zhengzhou Nanbei Instrument Equipment Co. Ltd.
- Zymo Research Corporation
